Literature DB >> 11546790

Binding of Fyn to MAP-2c through an SH3 binding domain. Regulation of the interaction by ERK2.

S P Zamora-Leon1, G Lee, P Davies, B Shafit-Zagardo.   

Abstract

Microtubule-associated protein 2 (MAP-2) isoforms are developmentally expressed in the nervous system and contain a number of functional domains. Adjacent to the first repeat of the microtubule-binding domain is an RTPPKSP motif for binding SH3 domains. To identify SH3-containing proteins that interact with MAP-2, transfections, filter overlay assays, glutathione S-transferase (GST)-mediated binding assays, co-immunoprecipitations and enzyme-linked immunosorbent assays were performed. Transfections of MAP-2a, MAP-2b, and MAP-2c constructs into COS7 cells, followed by incubation of the cell lysates with SH3-GST fusion proteins, determined that the strongest interaction was between MAP-2c and the non-receptor tyrosine kinase Fyn; however, MAP-2b and MAP-2c also bound to Grb2. Co-immunoprecipitation of Fyn and MAP-2c from human fetal homogenates confirmed the interaction in vivo. MAP-2 synthetic peptides spanning the RTPPKSP motif bound to Fyn, and the interaction was regulated by phosphorylation. Co-transfections with MAP-2c and the extracellular signal-regulated kinase 2 (ERK2) demonstrated that MAP-2c is threonine/serine-phosphorylated on its RTPPKSP motif and that threonine phosphorylation abolished the MAP-2c/Fyn binding. Kinase assays and co-transfection of MAP-2c and Fyn confirmed that Fyn tyrosine kinase phosphorylates MAP-2c. Thus, the activation of signaling pathways may regulate cytoskeletal dynamics by altering the state of phosphorylation of MAP-2 by both ERK2 and Fyn kinase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11546790     DOI: 10.1074/jbc.M107807200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  The protein phosphatase PP2A/Bα binds to the microtubule-associated proteins Tau and MAP2 at a motif also recognized by the kinase Fyn: implications for tauopathies.

Authors:  Jean-Marie Sontag; Viyada Nunbhakdi-Craig; Charles L White; Shelley Halpain; Estelle Sontag
Journal:  J Biol Chem       Date:  2012-03-08       Impact factor: 5.157

Review 2.  Networking with AKAPs: context-dependent regulation of anchored enzymes.

Authors:  Emily J Welch; Brian W Jones; John D Scott
Journal:  Mol Interv       Date:  2010-04

Review 3.  Fyn in Neurodevelopment and Ischemic Brain Injury.

Authors:  Renatta Knox; Xiangning Jiang
Journal:  Dev Neurosci       Date:  2015-02-17       Impact factor: 2.984

Review 4.  The cytoskeleton in oligodendrocytes. Microtubule dynamics in health and disease.

Authors:  Christiane Richter-Landsberg
Journal:  J Mol Neurosci       Date:  2007-12-04       Impact factor: 3.444

5.  Efficient protocol for backbone and side-chain assignments of large, intrinsically disordered proteins: transient secondary structure analysis of 49.2 kDa microtubule associated protein 2c.

Authors:  Jiří Nováček; Lubomír Janda; Radka Dopitová; Lukáš Žídek; Vladimír Sklenář
Journal:  J Biomol NMR       Date:  2013-07-23       Impact factor: 2.835

6.  Functionally specific binding regions of microtubule-associated protein 2c exhibit distinct conformations and dynamics.

Authors:  Kateřina Melková; Vojtěch Zapletal; Séverine Jansen; Erik Nomilner; Milan Zachrdla; Jozef Hritz; Jiří Nováček; Markus Zweckstetter; Malene R Jensen; Martin Blackledge; Lukáš Žídek
Journal:  J Biol Chem       Date:  2018-06-20       Impact factor: 5.157

7.  Tau potentiates nerve growth factor-induced mitogen-activated protein kinase signaling and neurite initiation without a requirement for microtubule binding.

Authors:  Chad J Leugers; Gloria Lee
Journal:  J Biol Chem       Date:  2010-04-07       Impact factor: 5.157

8.  Loss of tau and Fyn reduces compensatory effects of MAP2 for tau and reveals a Fyn-independent effect of tau on calcium.

Authors:  Guanghao Liu; Ramasamy Thangavel; Jacob Rysted; Yohan Kim; Meghan B Francis; Eric Adams; Zhihong Lin; Rebecca J Taugher; John A Wemmie; Yuriy M Usachev; Gloria Lee
Journal:  J Neurosci Res       Date:  2019-08-26       Impact factor: 4.164

9.  Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy.

Authors:  K Bhaskar; G A Hobbs; S-H Yen; G Lee
Journal:  Neuropathol Appl Neurobiol       Date:  2010-10       Impact factor: 8.090

Review 10.  Tau and tauopathies.

Authors:  Gloria Lee; Chad J Leugers
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.